Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Boehringer-Lilly tap into behavioural change for online diabetes programme

Part of the partners' Tradjenta marketing, My Well Planner offers personalised educational resources

Boehringer Ingelheim - Lilly Tradjenta diabetes My Well Planner

Boehringer Ingelheim and Lilly have launched a new online programme for type 2 diabetes patients in the US as part of their Tradjenta (linagliptin) marketing.

The free My Well Planner programme is modelled on a behavioural change approach that aims to help patients work with healthcare professionals to set personalised health goals.

It promotes simple lifestyle changes that can improve health, such as better eating habits and building physical activity into daily life and advances the idea that by setting, and achieving, small goals patients can build towards bigger goals in the future.

Diabetes already affects more than 8 per cent of Americans, and the US Centers for Disease Control and Prevention (CDC) projects that as many as one in three adults could have diabetes by 2050 if current trends continue.

David Pass, vice president of metabolism marketing at Boehringer Ingelheim Pharmaceuticals, said: “There is no one-size-fits-all approach to managing type 2 diabetes.

“The Boehringer Ingelheim and Lilly Diabetes Alliance is committed to helping the millions of Americans living with type 2 diabetes manage their health by providing resources, such as My Well Planner, as well as treatments, such as the Tradjenta and Jentadueto family of products.”

Tradjenta and Jentadueto, which combines Tradjenta with an older diabetes drug metformin, are the first products marketed under Boehringer and Lilly's 2011 diabetes alliance.

The companies have separately launched digital initiatives in diabetes this year – Lilly with a branded mobile app for Glucagon and Boehringer with a health management programme, but the new programme is their first major digital project together.

The My Well Planner programme, which can be found on the pharma companies' Tradjenta.com website, involves a self-assessment of patients' motivation levels, based on which it provides tailored tips. Patients are also given progress reports which they can share with their doctor.

17th September 2012

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics